Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

The Mutational Profile of Pediatric Therapy-Related Myeloid Neoplasms

Jason R Schwartz, MD PhD, Michael P Walsh, PhD, Jing Ma, PhD, Tamara Lamprecht, B.S., Raul C Ribeiro, MD, Jeffery M. Klco, MD PhD

Blood (2018) 132 (Supplement 1): 2775.

https://doi.org/10.1182/blood-2018-99-118995

Published: 2018

Journal Articles

Clinical Outcomes and Mutation Clearance in Children with Acute Myeloid Leukemia Treated with Low-Dose Chemotherapy Plus G-CSF for Remission Induction

Blood (2017) 130 (Supplement 1): 1397.

https://doi.org/10.1182/blood.V130.Suppl_1.1397.1397

Published: 2017

Journal Articles

Combining Gene Mutation with Gene Expression Data Improves Outcomes Prediction in Acute Promyelocytic Leukemia

Blood (2017) 130 (Supplement 1): 2696.

https://doi.org/10.1182/blood.V130.Suppl_1.2696.2696

Published: 2017

Journal Articles

Association between Nuclear SET Domain ( NSD ) Protein Lysine Methyltransferases (KMT) Expression and Poor Prognosis in Acute Promyelocytic Leukemia (APL) Patients Treated with ATRA and Anthracycline Protocol

Blood (2017) 130 (Supplement 1): 2702.

https://doi.org/10.1182/blood.V130.Suppl_1.2702.2702

Published: 2017

Journal Articles

Survival after Diffuse Large B-Cell Lymphoma Among Children, Adolescents and Young Adults in the Era of Immunotherapy: A Population-Based Study

Renata Abrahao, MD MSc, Raul C. Ribeiro, MD, Li Tao, PhD, Aaron S. Rosenberg, MD, Theresa H.M. Keegan, PhD MS

Blood (2017) 130 (Supplement 1): 4150.

https://doi.org/10.1182/blood.V130.Suppl_1.4150.4150

Published: 2017

Journal Articles

Pilot Study of Combined Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib with Sorafenib in Pediatric Patients with Relapsed/Refractory FLT3+Ve AML

Hiroto Inaba, MD PhD, John C Panetta, PhD, Daelynn R Buelow, PhD, Raul C. Ribeiro, MD, John R. Eckardt, MD, Sharyn D Baker, PharmD, PhD

Blood (2016) 128 (22): 3937.

https://doi.org/10.1182/blood.V128.22.3937.3937

Published: 2016

Journal Articles

Genomic Profiling Identifies Novel Mutations and Fusion Genes in Newly Diagnosed and Relapsed Pediatric FLT3-ITD-Positive AML

Daelynn R Buelow, PhD, Stanley Pounds, PhD, Yong-Dong Wang, Lei Shi, PhD, Yongjin Li, PhD, David Finkelstein, Sheila A Shurtleff, PhD, Geoffrey A. Neale, PhD, Hiroto Inaba, MD PhD, Raul C. Ribeiro, MD, Dominique Garrison, Shelley Orwick, BS, James S. Blachly, MD, John C. Byrd, MD, Karl Kroll, Tanja A. Gruber, MD PhD, Jeffrey E Rubnitz, MD PhD, Sharyn D Baker, PharmD, PhD

Blood (2016) 128 (22): 2838.

https://doi.org/10.1182/blood.V128.22.2838.2838

Published: 2016

Journal Articles

Clinical Outcome and Non-Synonymous Mutation Clearance in Chinese Children with Acute Myeloid Leukemia Treated with a Low-Intensity Induction Chemotherapy Regimen

Aili Chen, PhD, Yixin Hu, MD, Xin Liu, MD PhD, Jun Lu, MD, Peifang Xiao, MD, Xinchang Zheng, Jin Yang, Ya Zhang, Jingyi Yang, MD, Fuhong He, PhD, Pinpin Sui, Hailong He, MD, Yi Wang, MD PhD, Cheng Cheng, PhD, Raul C. Ribeiro, MD, Shaoyan Hu, MD PhD, Qianfei Wang, PhD

Blood (2016) 128 (22): 2848.

https://doi.org/10.1182/blood.V128.22.2848.2848

Published: 2016

Journal Articles

Asparaginase May Affect Mercaptopurine Tolerability in the Context of Multi-Agent Therapy for Acute Lymphoblastic Leukemia

Chengcheng Liu, PhD, Deqing Pei, Cheng Cheng, PhD, Jun J Yang, PhD, Kristine R Crews, PhD, John C Panetta, PhD, Xiangjun DeMeter, Sima Jeha, MD, John Sandlund, MD, Raul C. Ribeiro, MD, Jeffrey E Rubnitz, MD PhD, Monika L. Metzger, MD, Ching-Hon Pui, MD, William E. Evans, PharmD, Mary V. Relling, PharmD

Blood (2016) 128 (22): 179.

https://doi.org/10.1182/blood.V128.22.179.179

Published: 2016

Journal Articles

a Phase I Trial of Bendamustine in Combination with Clofarabine and Etoposide in Pediatric Patients with Relapsed or Refractory Hematologic Malignancies

Sima Jeha, MD, Monika L. Metzger, MD, Kristine R Crews, PhD, Patrick Campbell, MD PhD, Raul C. Ribeiro, MD, Cheng Cheng, PhD, Melissa Peyton, RN, Carl Panetta, PhD, Jun Yang, PhD, Ching-Hon Pui, MD, Deepa Bhojwani, MD

Blood (2016) 128 (22): 1628.

https://doi.org/10.1182/blood.V128.22.1628.1628

Published: 2016

Journal Articles

The Genomic Landscape of Pediatric Myelodysplastic Syndromes

Jason R. Schwartz, MD PhD, Michael P. Walsh, PhD, Jing Ma, PhD, Tamara Lamprecht, B.S., Shuoguo Wang, PhD, Gang Wu, PhD, John Easton, PhD, Raul C. Ribeiro, MD, Jeffery M. Klco, MD PhD

Blood (2016) 128 (22): 956.

https://doi.org/10.1182/blood.V128.22.956.956

Published: 2016

Journal Articles

Predictors of Early Death in Childhood Acute Promyelocytic Leukemia: Results of an International Retrospective Study

Oussama Abla, MD, Raul C. Ribeiro, MD, Anna Maria Testi, MD, Pau Montesinos Fernández, MD, Ursula Creutzig, MD, Lillian Sung, MD PhD, Giancarlo Di Giuseppe, BSc, Derek Stephens, MSc, Henrik Hasle, MD PhD, Gertjan J.L. Kaspers, MD PhD, Luciano Dalla-Pozza, MB BS FRACP, Alvaro Lassaletta, MD, Martin S. Tallman, MD, Franco Locatelli, MD, Dirk Reinhardt, MD, Johann Hitzler, MD FRCP (C), FAAP, Miguel A. Sanz, MD PhD

Blood (2015) 126 (23): 172.

https://doi.org/10.1182/blood.V126.23.172.172

Published: 2015

Journal Articles

Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination with Fludarabine and Cytarabine in Pediatric Patients with Relapsed or Refractory AML

Jeffrey E Rubnitz, MD PhD, Ronda Kaufman, PhD, Raul C. Ribeiro, MD, Boris Klebanov, MA, MS, Joel Ellis, PhD, Yosef Landesman, PhD, Hagop Youssoufian, MD, Tami Rashal, MD, Sharon Shacham

Blood (2015) 126 (23): 1345.

https://doi.org/10.1182/blood.V126.23.1345.1345

Published: 2015

Journal Articles

Predictors of Early Death and Survival Among Children, Adolescents and Young Adults with Acute Myeloid Leukemia in California, 1988-2011: A Population-Based Study

Renata Abrahão, MD MSc, Ruth H Keogh, DPhil, Daphne Y Lichtensztajn, MD MPH, Rafael Marcos-Gragera, MDPhD, Bruno C. Medeiros, MD, MIchel P Coleman, FFPH, Raul C. Ribeiro, MD, Theresa HM Keegan, PhD MSc

Blood (2015) 126 (23): 1323.

https://doi.org/10.1182/blood.V126.23.1323.1323

Published: 2015

Journal Articles

Tolerability of 6-Mercaptopurine (6MP) in Patients with Thiopurine Methyltransferase ( TPMT ) Heterozygosity in the Context of Multi-Agent Therapy for Acute Lymphoblastic Leukemia (ALL)

Chengcheng Liu, Deqing Pei, MS, Cheng Cheng, PhD, Jun J. Yang, PhD, Kristine Crews, PharmD, Wenjian Yang, PhD, Seth E. Karol, MD, Sima Jeha, MD, John T. Sandlund, MD, Raul C Ribeiro, MD, Jeffrey E Rubnitz, MD PhD, Monika L. Metzger, MD MS, Ching-Hon Pui, MD, William E. Evans, PharmD, Mary V. Relling, PharmD

Blood (2014) 124 (21): 3722.

https://doi.org/10.1182/blood.V124.21.3722.3722

Published: 2014

Journal Articles

Expression Profiling Of Selected Polycomb Complex Genes In Childhood Acute Myeloid Leukemia Revealed An Overexpression Of EZH2 In Acute Promyelocytic Leukemia

Amanda Faria Figueiredo, PhD student, Renata Binato, PhD, Andre Mencalha, PhD, Roberto Capela Matos, Master Science student, Raul C Ribeiro, MD, Maria Luiza Macedo Silva, PhD, Eliana Abdelhay, PhD, MSc

Blood (2013) 122 (21): 4895.

https://doi.org/10.1182/blood.V122.21.4895.4895

Published: 2013

Journal Articles

Prognostic Factors For Children With Acute Myeloid Leukemia Who Achieve Minimal Residual Disease-Negative Status After Induction Therapy

Seth E Karol, MD, Elaine Coustan-Smith, MS, Xueyuan Cao, PhD, Sheila A Shurtleff, PhD, Susana C Raimondi, PhD, John K Choi, MD, PhD, Raul C Ribeiro, MD, Gary V Dahl, MD, W Paul Bowman, MD, Jeffrey W Taub, MD, Barbara Degar, MD, Wing Leung, MD, PhD, James R Downing, MD, Ching-Hon Pui, MD, Jeffrey E Rubnitz, MD, PhD, Dario Campana, MD, PhD, Hiroto Inaba, MD, PhD

Blood (2013) 122 (21): 490.

https://doi.org/10.1182/blood.V122.21.490.490

Published: 2013

Journal Articles

Improved Prognosis for Older Adolescents with Acute Lymphoblastic Leukemia

Blood (2010) 116 (21): 498.

https://doi.org/10.1182/blood.V116.21.498.498

Published: 2010

Journal Articles

Excellent Outcome for ETV6/RUNX1 -Positive Childhood Acute Lymphoblastic Leukemia (ALL) with Contemporary Therapy

Blood (2010) 116 (21): 495.

https://doi.org/10.1182/blood.V116.21.495.495

Published: 2010

Journal Articles

Clinical Activity, Pharmacokinetics, and Pharmacodynamics of Sorafenib In Pediatric Acute Myeloid Leukemia.

Hiroto Inaba, MD, PhD, Jeffrey E Rubnitz, MD, PhD, Elaine Coustan-Smith, MS, Lie Li, Brian D Furmanski, PhD, Gerard P Mascara, Sheila A Shurtleff, PhD, Stanley B Pounds, PhD, Ching-Hon Pui, MD, Raul C Ribeiro, MD, Dario Campana, MD, PhD, Sharyn D Baker, PharmD, PhD

Blood (2010) 116 (21): 1073.

https://doi.org/10.1182/blood.V116.21.1073.1073

Published: 2010

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

The Mutational Profile of Pediatric Therapy-Related Myeloid Neoplasms

Clinical Outcomes and Mutation Clearance in Children with Acute Myeloid Leukemia Treated with Low-Dose Chemotherapy Plus G-CSF for Remission Induction

Combining Gene Mutation with Gene Expression Data Improves Outcomes Prediction in Acute Promyelocytic Leukemia

Association between Nuclear SET Domain ( NSD ) Protein Lysine Methyltransferases (KMT) Expression and Poor Prognosis in Acute Promyelocytic Leukemia (APL) Patients Treated with ATRA and Anthracycline Protocol

Survival after Diffuse Large B-Cell Lymphoma Among Children, Adolescents and Young Adults in the Era of Immunotherapy: A Population-Based Study

Pilot Study of Combined Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib with Sorafenib in Pediatric Patients with Relapsed/Refractory FLT3+Ve AML

Genomic Profiling Identifies Novel Mutations and Fusion Genes in Newly Diagnosed and Relapsed Pediatric FLT3-ITD-Positive AML

Clinical Outcome and Non-Synonymous Mutation Clearance in Chinese Children with Acute Myeloid Leukemia Treated with a Low-Intensity Induction Chemotherapy Regimen

Asparaginase May Affect Mercaptopurine Tolerability in the Context of Multi-Agent Therapy for Acute Lymphoblastic Leukemia

a Phase I Trial of Bendamustine in Combination with Clofarabine and Etoposide in Pediatric Patients with Relapsed or Refractory Hematologic Malignancies

The Genomic Landscape of Pediatric Myelodysplastic Syndromes

Predictors of Early Death in Childhood Acute Promyelocytic Leukemia: Results of an International Retrospective Study

Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination with Fludarabine and Cytarabine in Pediatric Patients with Relapsed or Refractory AML

Predictors of Early Death and Survival Among Children, Adolescents and Young Adults with Acute Myeloid Leukemia in California, 1988-2011: A Population-Based Study

Tolerability of 6-Mercaptopurine (6MP) in Patients with Thiopurine Methyltransferase ( TPMT ) Heterozygosity in the Context of Multi-Agent Therapy for Acute Lymphoblastic Leukemia (ALL)

Expression Profiling Of Selected Polycomb Complex Genes In Childhood Acute Myeloid Leukemia Revealed An Overexpression Of EZH2 In Acute Promyelocytic Leukemia

Prognostic Factors For Children With Acute Myeloid Leukemia Who Achieve Minimal Residual Disease-Negative Status After Induction Therapy

Improved Prognosis for Older Adolescents with Acute Lymphoblastic Leukemia

Excellent Outcome for ETV6/RUNX1 -Positive Childhood Acute Lymphoblastic Leukemia (ALL) with Contemporary Therapy

Clinical Activity, Pharmacokinetics, and Pharmacodynamics of Sorafenib In Pediatric Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only